Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11941497 | 1.00 | MEN1 (0.46) | MEN1KMT2ANPSR1LMNATSHR | |
| SCHEMBL28710888 | 0.81 | MEN1 (0.50) | MEN1KMT2ANPSR1LMNATSHR | |
| SCHEMBL3341865 | 0.79 | MEN1 (0.48) | MEN1KMT2ANPSR1LMNATSHR | |
| SCHEMBL11941483 | 0.76 | MEN1 (0.40) | MEN1KMT2ANPSR1LMNATSHR | |
| SCHEMBL9592601 | 0.76 | MEN1 (0.40) | MEN1KMT2ANPSR1LMNA | |
| SCHEMBL11941482 | 0.76 | MEN1 (0.40) | MEN1KMT2ANPSR1LMNATSHR | |
| SCHEMBL11941444 | 0.76 | MEN1 (0.40) | MEN1KMT2ANPSR1LMNA | |
| SCHEMBL6005836 | 0.75 | CYP3A4 (0.48) | MEN1KMT2ANPSR1LMNACYP3A4 | |
| SCHEMBL10690351 | 0.75 | KMT2A (0.46) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL28857096 | 0.73 | MEN1 (0.48) | MEN1KMT2ANPSR1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120190648-A1 | FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID | JUBAULT PHILIPPE (FR) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190648-A1 | FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID | OXGR1, GLRA1, OXER1 | MEN1 4257/4885KMT2A 3031/4885NPSR1 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.